MPM Bioventures 2018 is a Venture Capital Fund in Massachusetts with $706.25 mm assets under management, with a minimum investment of $100.00 k. It has 43 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
823687697
AUM ?
$706.25 mm
Address
MPM Bioventures 2018
450 KENDALL STREET
CAMBRIDGE
MA 02142
450 KENDALL STREET
CAMBRIDGE
MA 02142
Phone
617-425-9200
Ownership
Fund structure | AUM | Fund type |
---|---|---|
MPM Asset Management LLC | $1.70 bn | |
MPM Asset Management Investors BV2014 LLC | $16.92 mm | Venture Capital Fund |
MPM Asset Management Investors BV2018 LLC | $14.41 mm | Venture Capital Fund |
MPM Asset Management Investors BV4 LLC | $3.80 mm | Venture Capital Fund |
MPM Asset Management Investors BV5 LLC | $3.89 mm | Venture Capital Fund |
MPM Asset Management Investors Sunstates Fund LLC | $1.26 mm | Venture Capital Fund |
MPM Bio 2014 NVS Strategic Fund, L.P. | $46.74 mm | Venture Capital Fund |
MPM Bio IV NVS Strategic Fund, L.P. | $38.23 mm | Venture Capital Fund |
MPM Bio V NVS Strategic Fund, L.P. | $32.65 mm | Venture Capital Fund |
MPM Bioventures 2014 (B), L.P. | $28.49 mm | Venture Capital Fund |
MPM Bioventures 2014, L.P. | $439.68 mm | Venture Capital Fund |
MPM Bioventures 2018 (B), L.P. | $36.71 mm | Venture Capital Fund |
MPM Bioventures 2018, L.P. | $706.25 mm | Venture Capital Fund |
MPM Bioventures IV GMBH & Co. Beteiligungs KG | $2.38 mm | Venture Capital Fund |
MPM Bioventures Iv-qp, L.P. | $70.11 mm | Venture Capital Fund |
MPM Bioventures V, L.P. | $71.44 mm | Venture Capital Fund |
MPM Oncology Innovations Fund L.P. | $174.11 mm | Venture Capital Fund |
MPM Sunstates Fund, L.P. | $5.09 mm | Venture Capital Fund |
Oncology Investors of Texas Costim, LLC | $2.88 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13G/A
Dyne Therapeutics, Inc.
12 Feb 24
SC 13G/A
Dyne Therapeutics, Inc.
9 Feb 23
4
iTeos Therapeutics, Inc.
6 Jan 22
4
iTeos Therapeutics, Inc.
7 Dec 21
4
iTeos Therapeutics, Inc.
2 Dec 21
4
iTeos Therapeutics, Inc.
30 Nov 21
4
iTeos Therapeutics, Inc.
24 Nov 21
4
Entrada Therapeutics, Inc.
4 Nov 21
3
Entrada Therapeutics, Inc.
28 Oct 21
4
iTeos Therapeutics, Inc.
18 Oct 21